Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19
- Authors
- Kim, Sun Bean; Ryoo, Seungeun; Huh, Kyungmin; Joo, Eun-Jeong; Kim, Youn Jeong; Choi, Won Suk; Kim, Yae-Jean; Yoon, Young Kyung; Heo, Jung Yeon; Seo, Yu Bin; Jeong, Su Jin; Park, Dong-ah; Yu, Su-Yeon; Lee, Hyeon-Jeong; Kim, Jimin; Jin, Yan; Park, Jungeun; Peck, Kyong Ran; Choi, Miyoung; Yeom, Joon Sup
- Issue Date
- 3월-2021
- Publisher
- KOREAN SOC ANTIMICROBIAL THERAPY
- Keywords
- COVID-19; Clinical practice guidelines; Korea
- Citation
- INFECTION AND CHEMOTHERAPY, v.53, no.1, pp.166 - 219
- Indexed
- SCOPUS
KCI
- Journal Title
- INFECTION AND CHEMOTHERAPY
- Volume
- 53
- Number
- 1
- Start Page
- 166
- End Page
- 219
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/128516
- DOI
- 10.3947/ic.2021.0303
- ISSN
- 2093-2340
- Abstract
- Despite the global effort to mitigate the spread, coronavirus disease 2019 (COVID-19) has become a pandemic that took more than 2 million lives. There are numerous ongoing clinical studies aiming to find treatment options and many are being published daily. Some effective treatment options, albeit of variable efficacy, have been discovered. Therefore, it is necessary to develop an evidence-based methodology, to continuously check for new evidence, and to update recommendations accordingly. Here we provide guidelines on pharmaceutical treatment for COVID-19 based on the latest evidence.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.